Abbott India Limited (BOM:500488)
India · Delayed Price · Currency is INR 26,397
-426 (-1.59%)
At close: Mar 25, 2026
Abbott India Market Cap
Abbott India has a market cap or net worth of 560.93 billion as of March 26, 2026. Its market cap has decreased by -15.89% in one year.
Market Cap
560.93B
Enterprise Value
539.33B
Revenue
68.24B
Ranking
n/a
PE Ratio
36.80
Stock Price
26,397.35
Market Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 560.93B, an increase of 11,661.21%. That is a compound annual growth rate of 21.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 560.93B | -9.19% |
| Dec 31, 2025 | 617.71B | -2.27% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.44T |
| Lupin | 1.07T |
| Dr. Reddy's Laboratories | 1.05T |
| GlaxoSmithKline Pharmaceuticals | 390.99B |
| J. B. Chemicals & Pharmaceuticals | 333.26B |
| AstraZeneca Pharma India | 207.25B |
| Granules India | 150.80B |
| Jubilant Pharmova | 136.08B |